Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Ateronon, a nutritional supplement that
contains lycopene from tomatoes has a favorable effect on carotid atherosclerosis, lipid
levels, and other biomarkers of coronary heart disease.
The trial was stopped early due to insufficient financial support from the initial study
collaborator, Cambridge Theranostics Ltd. Collected patient data are sufficient for final
trial-based analyses to be conducted with financial support from the new study collaborator,
CamNutra Ltd. The data will still be analyzed according to the original study aims.